IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics
Summary
IonQ and CCRM have formed a strategic partnership to accelerate advanced therapeutic development using quantum and quantum-AI technologies. The collaboration includes an investment commitment into CCRM’s quantum-biotech initiatives and makes IonQ the core technology partner across CCRM’s global network of advanced therapy hubs. Initial work will focus on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapies. The first projects are expected to launch in Canada and Sweden in 2026. This deal extends IonQ’s push into life sciences and builds on its broader partnerships and acquisitions in Europe.
Classifications
industries
No industries detected
applications
Web and Content Management
AskAI Classifications
Labels
Quantum Cyber Security
Random Number Generation
Encryption Software
Linked Companies
ID Quantique
$1M to $5M
IonQ
$10M to $25M